These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 31928267)

  • 1. Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke.
    Lan L; Rong X; Shen Q; Gong H; Li X; Wang H; Li M; Pan J; Zhang X; Peng Y
    Int J Neurosci; 2020 Sep; 130(9):857-864. PubMed ID: 31928267
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
    JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in the Dual Antiplatelet Therapy Versus Alteplase for Patients with Minor Nondisabling Acute Ischemic Stroke: A Secondary Analysis of the ARAMIS Study.
    Qu HL; Sun XY; He C; Chen HS
    CNS Drugs; 2024 Aug; 38(8):649-659. PubMed ID: 38806883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis.
    Peng TJ; Schwamm LH; Fonarow GC; Hassan AE; Hill M; Messé SR; Coronado F; Falcone GJ; Sharma R
    JAMA Neurol; 2024 Jul; 81(7):722-731. PubMed ID: 38767894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry.
    Lee HL; Kim JT; Lee JS; Park MS; Choi KH; Cho KH; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Sun Oh M; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Lee J; Bae HJ
    Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e006474. PubMed ID: 33201737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet vs. R-tPA for acute mild ischemic stroke: A prospective, random, and open label multi-center study.
    Wang XH; Tao L; Zhou ZH; Li XQ; Chen HS
    Int J Stroke; 2019 Aug; 14(6):658-663. PubMed ID: 30907301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.
    Zinkstok SM; Roos YB;
    Lancet; 2012 Aug; 380(9843):731-7. PubMed ID: 22748820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of early antiplatelet administration in patients with acute ischemic stroke treated with alteplase (SEAPT-24).
    Wells DA; Davis LK; Saeed O; Jones GM; Elangovan C; Alexandrov AV; Krishnaiah B; March KL
    J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106868. PubMed ID: 36347149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
    Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
    Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
    BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study.
    Hou X; Li X; Wang X; Chen H
    Stroke Vasc Neurol; 2018 Dec; 3(4):263-267. PubMed ID: 30637134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Antiplatelet Therapy vs Alteplase in Adult Patients with Acute Minor Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Viana P; Relvas JH; Cabral TDD; Persson JE; Menegaz de Almeida A; Persson M; Marques MVO; Oliveira-Filho J
    J Thromb Thrombolysis; 2024 Aug; 57(6):929-935. PubMed ID: 38722520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
    van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Postma AA; Roosendaal SD; Krietemeijer GM; Yo LSF; de Maat MPM; Nieboer D; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
    JAMA Neurol; 2023 Jul; 80(7):714-722. PubMed ID: 37213122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack.
    Huang HY; Chen JH; Chi NF; Chen YC
    J Atheroscler Thromb; 2024 Jun; 31(6):904-916. PubMed ID: 38092384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial.
    Chen HS; Cui Y; Wang XH; Ma YT; Han J; Duan YJ; Lu J; Shen LY; Liang Y; Wang WZ; Wang H; Zhao Y; Zhang JT; Song YL; He XM; Li RH; Tao DB; Li J; Huang SM; Wang N; Hong M; Meng C; Zhang W; Wang DL; Nguyen TN;
    JAMA Neurol; 2024 May; 81(5):450-460. PubMed ID: 38466274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Early Bleeding with Dual Antiplatelet Therapy in Acute Stroke and Transient Ischemic Attack Regardless of NIHSS Admission.
    Scavasine VC; Barbosa RM; Lopes Neto FDN; Germininani FMB; Bazan R; Zétola VF; Massaro AR; Lange MC
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105677. PubMed ID: 33677312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.
    van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Wallace AC; Gurewich V; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
    Trials; 2022 Aug; 23(1):641. PubMed ID: 35945566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.